SI
SUPN icon

Scout Investments’s Supernus Pharmaceuticals SUPN Stock Holding History

Scout Investments’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$6.88M Sell
208,613
-33,716
-14% -$1.05M 0.18% 149
2024
Q2 		$6.48M Sell
242,329
-23,196
-9% -$672K 0.17% 160
2024
Q1 		$8.9M Sell
265,525
-16,875
-6% -$502K 0.22% 143
2023
Q4 		$8.17M Sell
282,400
-4,429
-2% -$117K 0.2% 153
2023
Q3 		$7.78M Sell
286,829
-8,329
-3% -$254K 0.18% 149
2023
Q2 		$8.91M Sell
295,158
-8,786
-3% -$307K 0.18% 156
2023
Q1 		$11M Sell
303,944
-3,558
-1% -$137K 0.22% 126
2022
Q4 		$11M Sell
307,502
-5,115
-2% -$178K 0.22% 122
2022
Q3 		$10.6M Sell
312,617
-8,816
-3% -$287K 0.22% 129
2022
Q2 		$9.3M Sell
321,433
-27,331
-8% -$783K 0.18% 143
2022
Q1 		$11.3M Sell
348,764
-9,953
-3% -$305K 0.18% 137
2021
Q4 		$10.5M Sell
358,717
-8,106
-2% -$246K 0.15% 179
2021
Q3 		$9.78M Sell
366,823
-12,613
-3% -$339K 0.15% 196
2021
Q2 		$11.7M Sell
379,436
-532
-0.1% -$16.3K 0.17% 174
2021
Q1 		$9.95M Buy
379,968
+90,940
+31% +$2.54M 0.15% 211
2020
Q4 		$7.27M Buy
289,028
+22,488
+8% +$484K 0.13% 237
2020
Q3 		$5.55M Buy
266,540
+37,424
+16% +$849K 0.12% 230
2020
Q2 		$5.44M Sell
229,116
-1,649
-0.7% -$36.4K 0.13% 215
2020
Q1 		$4.15M Sell
230,765
-12,690
-5% -$267K 0.12% 206
2019
Q4 		$5.78M Sell
243,455
-269,280
-53% -$6.54M 0.11% 205
2019
Q3 		$14.1M Sell
512,735
-146,546
-22% -$4.34M 0.28% 124
2019
Q2 		$21.8M Sell
659,281
-108,223
-14% -$3.71M 0.42% 75
2019
Q1 		$26.9M Sell
767,504
-72,513
-9% -$2.7M 0.55% 60
2018
Q4 		$27.9M Buy
840,017
+327,870
+64% +$14.1M 0.7% 43
2018
Q3 		$25.8M Sell
512,147
-82,949
-14% -$4.1M 0.53% 66
2018
Q2 		$35.6M Buy
595,096
+416,696
+234% +$21.6M 0.81% 22
2018
Q1 		$8.17M Sell
178,400
-416,462
-70% -$17.4M 0.2% 161
2017
Q4 		$23.7M Buy
594,862
+28,962
+5% +$1.14M 0.59% 51
2017
Q3 		$22.6M Buy
565,900
+399,225
+240% +$17.3M 0.62% 55
2017
Q2 		$7.18M Buy
166,675
+4,225
+3% +$150K 0.21% 153
2017
Q1 		$5.08M Sell
162,450
-10,450
-6% -$280K 0.14% 167
2016
Q4 		$4.37M Buy
172,900
+250
+0.1% +$5.59K 0.12% 165
2016
Q3 		$4.27M Buy
172,650
+350
+0.2% +$7.92K 0.12% 165
2016
Q2 		$3.51M Buy
172,300
+7,850
+5% +$139K 0.1% 173
2016
Q1 		$2.51M Buy
164,450
+39,800
+32% +$519K 0.07% 202
2015
Q4 		$1.68M Buy
124,650
+66,625
+115% +$1.03M 0.04% 229
2015
Q3 		$814K Buy
+58,025
New +$1.08M 0.02% 242

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Scout Investments's SUPN Position: Q3 2024 in Review

Scout Investments reduced its Supernus Pharmaceuticals (SUPN) stake by 14% in Q3 2024, selling an estimated $1.05M and leaving 208,613 shares worth $6.88M. The position accounts for 0.18% of the portfolio, ranked #149.

Scout Investments first reported a position in SUPN in Q3 2015 and has held it in 37 quarters since. The position peaked at $35.6M in Q2 2018. 273 funds tracked by Wall St. Rank hold SUPN as of Q3 2024.

  • Scout Investments held 208,613 shares of Supernus Pharmaceuticals worth $6.88M as of Q3 2024.
  • Scout Investments sold 33,716 Supernus Pharmaceuticals shares in Q3 2024, an estimated $1.05M.
  • Supernus Pharmaceuticals made up 0.18% of Scout Investments's portfolio in Q3 2024, its #149 holding.
  • Scout Investments first reported a position in Supernus Pharmaceuticals in Q3 2015 and has held it in 37 quarters since.
  • Scout Investments's Supernus Pharmaceuticals position peaked at $35.6M in Q2 2018.
  • 273 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2024.

Based on Scout Investments's 13F filing for Q3 2024, filed 12 Nov 2024.